| Mapping the human genetic architecture of COVID-19 MEK Niemi, J Karjalainen, RG Liao, BM Neale, M Daly, A Ganna, L Davis, ... Nature 600 (7889), 472-477, 2021 | 970* | 2021 |
| The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang, Z Cui, L Lin, X Hu, X Yu, ... Nature communications 11 (1), 1600, 2020 | 217 | 2020 |
| Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations NJ Lennon, LC Kottyan, C Kachulis, NS Abul-Husn, J Arias, G Belbin, ... Nature Medicine 30 (2), 480-487, 2024 | 168 | 2024 |
| Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy K Kiryluk, E Sanchez-Rodriguez, XJ Zhou, F Zanoni, L Liu, N Mladkova, ... Nature genetics 55 (7), 1091-1105, 2023 | 166 | 2023 |
| Cell subtype-specific effects of genetic variation in the Alzheimer’s disease brain M Fujita, Z Gao, L Zeng, C McCabe, CC White, B Ng, GS Green, ... Nature Genetics 56 (4), 605-614, 2024 | 165 | 2024 |
| Genome-wide polygenic score to predict chronic kidney disease across ancestries A Khan, MC Turchin, A Patki, V Srinivasasainagendra, N Shang, ... Nature medicine 28 (7), 1412-1420, 2022 | 158 | 2022 |
| Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations T Ge, MR Irvin, A Patki, V Srinivasasainagendra, YF Lin, HK Tiwari, ... Genome Medicine 14 (1), 70, 2022 | 154 | 2022 |
| Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality T Nakanishi, S Pigazzini, F Degenhardt, M Cordioli, G Butler-Laporte, ... The Journal of clinical investigation 131 (23), 2021 | 132 | 2021 |
| Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure MG Levin, NL Tsao, P Singhal, C Liu, HMT Vy, I Paranjpe, JD Backman, ... Nature communications 13 (1), 6914, 2022 | 130 | 2022 |
| Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19 JE Huffman, G Butler-Laporte, A Khan, E Pairo-Castineira, TG Drivas, ... Nature genetics 54 (2), 125-127, 2022 | 122 | 2022 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 112 | 2023 |
| Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 G Povysil, G Butler-Laporte, N Shang, C Wang, A Khan, M Alaamery, ... The Journal of clinical investigation 131 (14), 2021 | 88 | 2021 |
| Generalizability of polygenic risk scores for breast cancer among women with European, African, and Latinx ancestry C Liu, N Zeinomar, WK Chung, K Kiryluk, AG Gharavi, G Hripcsak, ... JAMA network open 4 (8), e2119084-e2119084, 2021 | 79 | 2021 |
| Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies N Shang, A Khan, F Polubriaginof, F Zanoni, K Mehl, D Fasel, PE Drawz, ... NPJ digital medicine 4 (1), 70, 2021 | 73 | 2021 |
| CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses Z Yang, C Wang, L Liu, A Khan, A Lee, B Vardarajan, R Mayeux, K Kiryluk, ... Nature Genetics 55 (6), 1057-1065, 2023 | 71 | 2023 |
| Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease Y Gupta, DJ Friedman, MT McNulty, A Khan, B Lane, C Wang, J Ke, G Jin, ... Nature communications 14 (1), 7836, 2023 | 63 | 2023 |
| Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits L Liu, A Khan, E Sanchez-Rodriguez, F Zanoni, Y Li, N Steers, O Balderes, ... Nature communications 13 (1), 6859, 2022 | 55 | 2022 |
| Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis COVID-19 Host Genetics Initiative, A Ganna MedRxiv, 2021.03. 10.21252820, 2021 | 55 | 2021 |
| Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy Z Moldoveanu, H Suzuki, C Reily, K Satake, L Novak, N Xu, ZQ Huang, ... Journal of autoimmunity 118, 102593, 2021 | 53 | 2021 |
| Polygenic risk alters the penetrance of monogenic kidney disease A Khan, N Shang, JG Nestor, C Weng, G Hripcsak, PC Harris, AG Gharavi, ... Nature communications 14 (1), 8318, 2023 | 49 | 2023 |
